Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Lung Tuberculosis
74%
Tuberculostatic Agent
53%
Epidermal Growth Factor Receptor
51%
Lung Adenocarcinoma
46%
Mycobacterium Tuberculosis
46%
Chemotherapy
37%
Isoniazid
35%
Non Small Cell Lung Cancer
33%
Diabetes Mellitus
32%
Drug Resistance
29%
Connective Tissue Growth Factor
27%
Bacteremia
27%
Imipenem
27%
Multi-Drug-Resistant Tuberculosis
27%
Inflammation
22%
Ethambutol
22%
Tuberculosis
22%
Pharmacokinetics
21%
Pleura Effusion
21%
Rifampicin
21%
Biological Marker
19%
Nephrotoxicity
18%
Asthma
18%
Liver Disease
18%
Sulbactam
18%
Carbon Black
18%
Ventilator Associated Pneumonia
18%
Nuclear Factor
18%
Alternative Complement Pathway C3 C5 Convertase
18%
Extended Spectrum Beta Lactamase
18%
Uridine Diphosphate
18%
Acinetobacter Baumannii
18%
Tigecycline
18%
Thrombin
18%
Community Acquired Pneumonia
18%
Comorbidity
16%
Infection
16%
Drug Resistant Tuberculosis
15%
Disease
13%
Overall Survival
13%
Malignant Neoplasm
13%
Protein Tyrosine Kinase Inhibitor
12%
Atypical Mycobacterium
12%
Isoniazid Plus Rifampicin
12%
Penicillinase
12%
Enterobacteriaceae
12%
Effusion
11%
Escherichia coli
11%
Chronic Disease
11%
Medicine and Dentistry
Lung Tuberculosis
83%
Lung Cancer
78%
Multidrug Resistant Tuberculosis
59%
Diabetes Mellitus
43%
Epidermal Growth Factor Receptor
35%
Diabetes
28%
Tuberculosis
28%
Lung Adenocarcinoma
28%
Intensive Care Unit
27%
Tuberculosis Treatment
23%
Mycobacterium Tuberculosis
23%
Mortality Rate
21%
Disease
20%
Atmospheric Aerosol
19%
Personalized Medicine
19%
Non Small Cell Lung Cancer
19%
Sleep Quality
18%
Short Course Therapy
18%
Glycemic Control
18%
Breast Cancer
18%
Cancer Risk
18%
Electronic Patient Record
18%
Community-Acquired Pneumonia
18%
Prostate Cancer
18%
Atypical Mycobacterium
18%
Nephrotoxicity
18%
Extended Spectrum Beta Lactamase
18%
Infection
15%
Pleura Effusion
14%
Chest Radiograph
14%
Isoniazid
12%
Public Health
12%
Clinician
12%
Tyrosine-Kinase Inhibitor
12%
Enterobacteriaceae
12%
Penicillinase
12%
Particular Matter 2.5
11%
Cancer Cell
11%
Drug Resistance
11%
Mammalian Target of Rapamycin
11%
Effusion
11%
Odds Ratio
11%
Ethambutol
11%
Escherichia coli
11%
Cohort Analysis
11%
Biological Marker
11%
Drug Therapy
10%
Hemoptysis
10%
Klebsiella pneumoniae
10%
Enterobacter Cloacae
10%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
42%
Fibroblast
28%
Connective Tissue Growth Factor
27%
STAT3
25%
Pharmacokinetics
22%
Genome Sequencing
18%
Hope
18%
Translating (Language)
18%
Pharmacogenomics
18%
Phosphotransferase
18%
Kinase
18%
Thrombin
18%
Autophagy
18%
Mammalian Target of Rapamycin
11%
Cancer Cell
11%
Janus Kinase
10%
Signal Transduction
9%
Overall Survival
9%
Smoking
9%
Tumor Suppressor Protein
9%
Wart Virus
9%
N-Terminus
9%
Electronic Medical Record
9%
Genotyping
9%
Sphingosine-1-Phosphate
9%
Extracellular Signal-Regulated Kinases
9%
AP-1 Transcription Factor
9%
Ribosomal S6 Kinase
9%
Antiangiogenic Activity
9%
Ccaat-Enhancer-Binding Proteins
9%
Computerized Provider Order Entry
9%
Blood Level
9%
Low Drug Dose
9%
Cyclin-Dependent Kinase
9%
Uridine Diphosphate
9%
Vascular Endothelial Growth Factor
9%
Streptozotocin
9%
P53
9%
Metalloendopeptidase
9%
Histone Deacetylase
9%
Hyaluronan Synthase
9%
Disintegrin
9%
Metalloproteinase
9%
Transforming Growth Factor
9%
Genetic Risk
9%
Telomerase Reverse Transcriptase
9%
Alpha Oxidation
9%
Oncogene Src
9%
Particulate Matter
9%
Case-Control Study
9%
